Accretive Health Provides Update Regarding Delayed Filing of Form 10-K

CHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (the “Company”) previously indicated in its Form 12b-25 filed with the Securities and Exchange Commission (the “Commission”) on March 4, 2013 that the Company expected to receive a letter from the New York Stock Exchange (“NYSE”) indicating that the Company is not in compliance with the continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE-Listed Company Manual as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The Company did not timely file the Form 10-K because of the Company's review of the timing of revenue recognition for revenue cycle management services contracts and the pending restatement of the Company's financial statements. On March 19, 2013, the Company received such a letter from the NYSE. The letter is routine practice under NYSE rules when a listed company does not make a timely filing with the Commission.